EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock enjoyed a major increase of 177.5% on 12/4/23. The shares closed at $18.34. Moreover, exceptionally high trading volume at 2214% of normal accompanied the advance. The stock has risen 198.7% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, EYPT is expected to continue to be a modest Value Eraser.
EyePoint Pharmaceuticals has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. EyePoint Pharmaceuticals has a very low Appreciation Score of 10 but a very high Power Rating of 97, and the Neutral Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment